Disc Medicine IRON
$75.14 −$0.97 (-1.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $75.14 0.00%
Open$75.20
Prev close$76.11
Day range$74.54 – $77.01
Volume561.6K
Market cap$3.42B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$64.16M+5.2% YoY
Net profit-$59.54M+4.5% YoY
Diluted EPS-$1.53+13.6% YoY
Free cash flow-$40.20M+15.9% YoY
Operating cash flow-$40.20M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-41.3%
Return on assets-36.6%
Return on invested capital-40.5%
Current ratio20.30
Liabilities / assets13.6%
Cash & investments$682.82M
Total debt$60.88M
Net cash (debt)$621.94M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $64.16M | $65.08M | $69.52M | $236.02M | $66.97M |
| Selling and Admin Expenses | $20.08M | $18.14M | $23.62M | $65.38M | $20.75M |
| -General & Admin Expense | $20.08M | $18.14M | $23.62M | $65.38M | $20.75M |
| Research & Development | $44.08M | $46.93M | $45.90M | $170.64M | $46.22M |
| Operating Profit | -$64.16M | -$65.08M | -$69.52M | -$236.02M | -$66.97M |
| Net Non-Operating Interest Income (Expense) | $4.74M | $5.62M | $6.05M | $24.15M | $6.53M |
| Non-Operating Interest Income | $6.45M | $6.53M | $6.89M | $27.76M | $7.41M |
| Non-Operating Interest Expense | $1.71M | $908,000.00 | $844,000.00 | $3.61M | $883,000.00 |
| Other Income (Expense) | -$5,000.00 | -$12,000.00 | $22,000.00 | $45,000.00 | -$2,000.00 |
| Other Non-Operating Income (Expenses) | -$5,000.00 | -$12,000.00 | $22,000.00 | $45,000.00 | -$2,000.00 |
| Pretax Profit | -$59.43M | -$59.46M | -$63.45M | -$211.82M | -$60.44M |
| Tax | $109,000.00 | $69,000.00 | $51,000.00 | $361,000.00 | $88,000.00 |
| Net Profit | -$59.54M | -$59.53M | -$63.50M | -$212.18M | -$60.53M |
| Profit from Continuing Operations | -$59.54M | -$59.53M | -$63.50M | -$212.18M | -$60.53M |
| Net Income to Parent Company | -$59.54M | -$59.53M | -$63.50M | -$212.18M | -$60.53M |
| Net Income to Common Stockholders | -$59.54M | -$59.53M | -$63.50M | -$212.18M | -$60.53M |
| Basic EPS | -$1.53 | -$1.54 | -$1.65 | -$6.01 | -$1.62 |
| Diluted EPS | -$1.53 | -$1.54 | -$1.65 | -$6.01 | -$1.62 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $699.49M | $735.07M | $750.21M | $806.88M | $806.88M |
| Total Current Assets | $697.41M | $732.76M | $747.46M | $803.90M | $803.90M |
| Cash and Cash Equivalents & Short-Term Investments | $682.82M | $717.75M | $730.16M | $791.15M | $791.15M |
| -Cash and Cash Equivalents | $89.98M | $98.68M | $88.91M | $91.15M | $91.15M |
| -Short Term Investments | $592.83M | $619.07M | $641.25M | $700.01M | $700.01M |
| Other Current Assets | $14.59M | $15.02M | $17.30M | $12.75M | $12.75M |
| Total Non-Current Assets | $2.08M | $2.31M | $2.76M | $2.98M | $2.98M |
| Net PPE | $1.59M | $1.81M | $2.04M | $2.26M | $2.26M |
| -Gross PPE | $1.59M | $1.81M | $2.04M | $2.26M | $2.26M |
| Other Non-Current Assets | $496,000.00 | $496,000.00 | $721,000.00 | $726,000.00 | $726,000.00 |
| Total Liabilities | $95.24M | $90.91M | $61.78M | $67.05M | $67.05M |
| Total Current Liabilities | $34.36M | $30.36M | $31.14M | $36.64M | $36.64M |
| Payables | $6.07M | $6.84M | $11.76M | $9.02M | $9.02M |
| -Accounts Payable | $6.07M | $6.84M | $11.76M | $9.02M | $9.02M |
| Current Accrued Expenses | $26.40M | $16.84M | $14.47M | $14.37M | $14.37M |
| Short-Term Debt and Capital Lease Obligation | $209,000.00 | $315,000.00 | $419,000.00 | $611,000.00 | $611,000.00 |
| -Current Capital Lease Obligation | $209,000.00 | $315,000.00 | $419,000.00 | $611,000.00 | $611,000.00 |
| Total Non-Current Liabilities | $60.88M | $60.55M | $30.64M | $30.41M | $30.41M |
| Long Term Debt and Capital Lease Obligation | $60.88M | $60.55M | $30.64M | $30.41M | $30.41M |
| -Long Term Debt | $59.75M | $59.34M | $29.37M | $29.16M | $29.16M |
| -Long Term Capital Lease Obligation | $1.13M | $1.21M | $1.28M | $1.25M | $1.25M |
| Total Equity | $604.25M | $644.16M | $688.43M | $739.83M | $739.83M |
| Stockholders' Equity | $604.25M | $644.16M | $688.43M | $739.83M | $739.83M |
| Capital Stock | $4,000.00 | $4,000.00 | $4,000.00 | $4,000.00 | $4,000.00 |
| -Common Stock | $4,000.00 | $4,000.00 | $4,000.00 | $4,000.00 | $4,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.30B | $1.28B | $1.26B | $1.25B | $1.25B |
| Retained Earnings | -$692.76M | -$633.22M | -$573.69M | -$510.19M | -$510.19M |
| Gains/Losses Not Affecting Retained Earnings | -$2.77M | -$1.61M | -$571,000.00 | $965,000.00 | $965,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$40.20M | -$44.20M | -$62.24M | -$180.39M | -$43.30M |
| Net cash flow from continuing operations | -$40.20M | -$44.20M | -$62.24M | -$180.39M | -$43.30M |
| Net Income from Continuing Operations | -$59.54M | -$59.53M | -$63.50M | -$212.18M | -$60.53M |
| Depreciation & Depletion & Amortization | $90,000.00 | $90,000.00 | $89,000.00 | $281,000.00 | $89,000.00 |
| Other Non-Cash Items | $545,000.00 | $352,000.00 | $323,000.00 | $2.16M | $336,000.00 |
| Change in Working Capital | $4.35M | $1.43M | -$10.02M | $3.53M | $8.40M |
| -Change in Prepaid Assets | $426,000.00 | $2.28M | -$4.55M | -$8.92M | -$1.38M |
| -Change in Payables and Accrued Expense | $4.11M | -$678,000.00 | -$5.31M | $12.26M | $9.94M |
| -Change in Other Current Liabilities | -$180,000.00 | -$174,000.00 | -$168,000.00 | $186,000.00 | -$165,000.00 |
| Net cash flow from investing | $25.33M | $21.63M | $58.31M | -$394.30M | -$222.89M |
| Net Cash Flow from Continuing Investing Activities | $25.33M | $21.63M | $58.31M | -$394.30M | -$222.89M |
| Net PPE Purchase and Sale | $0.00 | $0.00 | $0.00 | -$933,000.00 | -$20,000.00 |
| Net Investment Purchase and Sale | $25.33M | $21.63M | $58.31M | -$393.37M | -$222.87M |
| Financing Cash Flow | $6.18M | $32.34M | $1.70M | $473.41M | $216.68M |
| Net Cash Flow from Continuing Financing Activities | $6.18M | $32.34M | $1.70M | $473.41M | $216.68M |
| Net Issuance Payments Of Debt | $0.00 | – | – | $0.00 | $0.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | $0.00 | $450.11M | $206.34M |
| Proceeds from Stock Option Exercised | $6.18M | $2.36M | $1.70M | $23.30M | $10.33M |
| Ending Cash Balance | $90.23M | $98.92M | $89.16M | $91.39M | $91.39M |
| Net Change in Cash | -$8.69M | $9.76M | -$2.23M | -$101.29M | -$49.52M |
| Beginning Cash Balance | $98.92M | $89.16M | $91.39M | $192.67M | $140.90M |
| Free Cash Flow | -$40.20M | -$44.20M | -$62.24M | -$181.33M | -$43.32M |
No comments yet — be the first to weigh in on IRON.
Sign in to join the discussion.